News Tauklarify PET approval for Lantheus in AD NFT pathology The FDA approves Lantheus' Tauklarify radiodiagnostic PET to evaluate NFT pathology in Alzheimer's disease.
News UK launches total-body PET drive to support drug discovery The UK has launched an initiative that will coordinate the activities of two total-body PET imaging centres in England and Scotland, harvesting data that will be made avai
Partner Content Partner Content Medicines Discovery Catapult relaunches Wolfson Radiochemist... MDC relaunches Wolfson Radiochemistry facility
News Iambic prices its IPO, seeking to raise up to $160m AI-powered drug discovery company Iambic Therapeutics has announced the terms of its Nasdaq IPO, pitching at a valuation of more than $800m.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
